Efficacy and safety of switching from lopinavir/r to atazanavir/r in suppressed patients receiving a LPV/r-containing HAART: ATAZIP 96-week results

Mallolas, J; Podzamczer, D; Domingo, P; Echeverría, P; Ribera, E; Gutierrez, F; Knobel, H; Cosín, J; Ferrer, E; Arranz, JA; Roca, V; Pich, J; de Lazzari, E; Gatell, JM

doi:10.1186/1758-2652-11-S1-P53

Journal of the International AIDS Society

Article metrics
Last updated: Thu, 18 Apr 2024 16:39:00 Z

Efficacy and safety of switching from lopinavir/r to atazanavir/r in suppressed patients receiving a LPV/r-containing HAART: ATAZIP 96-week results

Access & Citations

1186

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.